Your browser doesn't support javascript.
loading
MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42.
Chou, Jinjiang; Wang, Bingyu; Zheng, Tianjing; Li, Xiaoman; Zheng, Lufeng; Hu, Jinhang; Zhang, Yan; Xing, Yingying; Xi, Tao.
Afiliação
  • Chou J; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
  • Wang B; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
  • Zheng T; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
  • Li X; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jingsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine
  • Zheng L; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
  • Hu J; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
  • Zhang Y; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
  • Xing Y; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
  • Xi T; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China. Electronic a
Biochem Biophys Res Commun ; 472(1): 262-9, 2016 Mar 25.
Article em En | MEDLINE | ID: mdl-26926567
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína cdc42 de Ligação ao GTP / MicroRNAs / RNA Longo não Codificante Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína cdc42 de Ligação ao GTP / MicroRNAs / RNA Longo não Codificante Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article